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Abstract: 
 Objectives: 
The aim of this study was to determine how tobacco control interest groups influence 
tobacco policy decision-making through submissions and presentations to parliamentary 
committees.   
 Methods: 
A qualitative content analysis was used to examine the presentations and submissions 
made to parliamentary committees.  The sample was composed of submissions and presentations 
made to parliamentary committees regarding tobacco-related legislation between 1996 and 2004.  
The sample was identified from the public list of tobacco-related bills tabled in both the House of 
Commons and the Senate, and using the Government of Canada website and LEGISinfo to 
determine which committee reviewed the relevant bill.  Committee clerks were asked to send 
submissions and presentations related to specific bills identified through LEGISinfo.  
Submissions and presentations were scanned and entered into QSR N6 for coding.  The coding 
instrument was adapted from previous studies employing qualitative content analysis.  Montini 
and Bero’s1 recommendations were used to evaluate the submissions and presentations.   
 Results: 
 Tobacco control interest groups did present scientific evidence to support tobacco 
control.  However, they underutilized the use of credible witnesses to present information at 
meetings.  The topics presented by tobacco control interests groups were usually relevant to the 
bill being discussed. 
 Conclusion: 
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 Tobacco Control interest groups employed some of the strategies suggested by Montini 
and Bero’s1 in their attempt to influence parliament committees through submissions and 
presentations.  They did include scientific evidence in their submissions; however, they can 
improve in the area of using credible witnesses, such as scientists and medical experts.  
Incorporating Montini and Bero’s1 recommendations into lobbying efforts may increase success 
in influencing committees. 
Keywords: Public Health; lobbying; tobacco; consumer advocacy; federal government; Canada
 4 
Introduction 
Health advocacy, a strategy of pressuring governments for legislative and regulatory 
changes that improve health, is an essential part of health promotion and public health policy.  
Interest groups engage in health advocacy by providing the public and policy-makers with 
information (e.g., technical or scientific), and lobbying policy-makers both in public forums and 
private forums to support particular positions.2   
 Tobacco control is an issue that evokes strong reactions from various stakeholders 
because it sits at the interface of individual versus collective rights, and health improvements 
versus tax revenues.  Of all stakeholders, the tobacco industry has the most political clout given 
their wealth, despite their  low credibility and a poor reputation.3-4  Thus, the inclusion of 
tobacco control interest groups (e.g.,  the Non-Smokers’ Rights Association, Physicians for a 
Smoke-Free Canada or the Canadian Cancer Society) in tobacco control deliberations is 
necessary to advocate for public health.  Otherwise, the tobacco industry and its interests might 
dominate policy discussions.  This is occurring in other countries, for example, in Argentina, 
where tobacco control legislation is seen as weak due to strong industry  pressure and an inability 
to learn from the experience of other countries.5  In Asia, the tobacco industry, in its efforts to 
counter and delay the process of tobacco control legislation and tobacco control regulations, is 
attempting to undermine tobacco control advocacy groups, including the World Health 
Organization and Asia Pacific Association of Control Tobacco.6  Effective health advocacy is 
required from tobacco control interest groups in order to achieve optimal tobacco control 
legislation.7 
Some researchers have come to the conclusion that public forums are the most effective 
means of lobbying the government for change.8  An important finding from studies of lobbying 
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in different forums is that legislators have more positive attitudes toward non-for-profit health 
organizations and medical professional groups than toward the tobacco industry lobbyists.9  
However, legislators reported not having enough contact with non-for-profit health 
organizations.9  Another study indicated that US Food and Drug Administration committees, 
required to review every document submitted, took note when documents were submitted 
multiple times, which may disadvantage coalitions that act on behalf of many organizations.10  
Committee members also noted how the tobacco industry and tobacco control interest groups 
used the same scientific articles to support their differing arguments.10  Recent and peer reviewed 
articles also attracted officials’ attention.11  While these studies have focused on committee 
members’ perceptions of viewed material, there is a lack of systematic understanding about the 
characteristics of the submissions or presentations.  
The purpose of this study was to determine how Canadian tobacco control interest groups 
attempt influence tobacco policy decision-making in their written submissions and presentations 
to Canadian parliamentary committees.  It is important to understand how this set of advocacy 
material comes across as a whole.  By doing so, tobacco control interest groups can refine their 
presentation strategies to legislative and regulatory committees to effectively meet the groups’ 
intended outcomes.  According to Montini and Bero’s1 study, based on interviews with policy 
makers, tobacco control interest groups should 1) present scientific evidence to support tobacco 
control, 2) offer credible witnesses to present at meetings, and 3) need to understand factors, 
outside of science, that affect policy-making, for example timing of legislation and lobbying 
pressure.  These recommendations were used to develop research  questions with which to 
evaluate the presentations and submissions; however the study design did not allow the authors 
to examine the third recommendation.  We asked if the tobacco control interest groups involved 
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in health advocacy: 1) provide scientific evidence to support tobacco control? 2) offer credible 
witnesses to present at meetings?  and 3)  present content themes that were consistent with the 
theme of the bill under consideration?   
Methods 
 Design: 
This study employed a qualitative content analysis, using a coding instrument adapted 
from Durrant, Wakefield, McLeod, Clegg-Smith and Chapman,12 and Wenger, Malone and 
Bero13.  The coding instrument was used to examine the presentations and submissions to 
parliamentary committees reviewing tobacco control legislation.  The coding instrument is 
discussed in more detail in the Data Collection/Instrument section below.  A pilot test was 
conduct with two coders to refine the instrument.  Operational definitions of the codes were 
developed and a single coder (the primary author) was used to increase rigor.  The study used 
publicly available documents and not confidential or personal data; thus an ethics review was not 
required. 
Sample: 
LEGISinfo and other Government of Canada websites were used to compile a list of bills 
tabled between the 35th Parliament 2nd Session and the 37th Parliament 3rd Session (February 27, 
1996 to May 23, 2004).  This eight year time period was advantageous in that it included many 
milestones in tobacco control legislation.  Also, starting with the 35th Parliament 2nd Session, 
transcripts of committee meetings are readily available online.  No bills involving tobacco 
control have gone to committee since the end of the 37th Parliament 3rd Session.  The bill 
number, title, date of first reading, committee referrals, and furthest stage or date of Royal 
Assent were recorded.  Ten bills regarding tobacco were identified as having gone to committee 
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during this time period.  These committees include The House of Commons Standing Committee 
on Finance, The House of Commons Standing Committee on Health, The Senate Standing 
Committee on Social Affairs, Science and Technology; The Senate Standing Committee Legal 
and Constitutional Affairs; The Senate Standing Committee Energy, the Environment and 
Natural Resources; and The Standing Senate Committee on Banking, Trade, and Commerce.  
The clerks for the identified committees were contacted by email and requested to send any 
submissions to the committee regarding the specified bills.  Four of the committee clerks sent the 
requested submissions in relation to nine bills; however, two bills were excluded because the 
submissions only included speaking notes and no further submissions (Table 1). 
The committee meeting minutes and transcripts are available on parliamentary committee 
websites for bills introduced from the 35th parliament 2nd session onward.  This information was 
used to make a list of presenters and organizational affiliations.  The presentations analyzed in 
this study were extracted from these transcripts.  The documents were catalogued, recording the 
committee to which they were submitted, the bill they concerned, the individual or organization 
making the submission, the date of submission (if available), and the title of submission.  This 
list was then compared to the list of presenters to identify pairs of submissions and committee 
testimony. 
Data Collection/Instrument: 
The submissions were scanned and entered into QSR N6 for coding.  The coding 
instrument was an adaptation of those used in other tobacco-related studies that employ content 
analysis.12-13  The coding instrument included information on the committee to which the 
presentation or submission was made, the bill it concerned, which organization made the 
presentation or submission, if they supported or opposed the bill, any recommendations made, 
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type of document (for example presentation, brief, research, newsletter), use of scientific 
evidence, and themes (for example tobacco advertising, promotion and sponsorship; youth 
smoking issues; and tobacco industry; legislation and regulation).  For more information 
regarding the coding instrument, see Table 2.   
Analysis 
Emerging and predetermined themes were developed and refined during the coding 
process to reflect the analytical framework.  The thematic categories were not mutually 
exclusive.  Interpretations of findings were on-going during the coding and analysis process, and 
were conducted through deliberate discussions between the authors.  The themes derived from 
the content analysis were compared to the themes in the bills to determine if the themes 
presented were on topic. 
Results and Discussion 
The sample consisted of twenty-one presentations and thirty-nine submissions written in 
English.  The submissions and presentations related to seven bills made to four parliamentary 
committees.  The most common type of document submitted to committees were briefs prepared 
by tobacco control interest groups (n=12).  The second largest category of documents were 
journal articles that the interest groups used to support their opinion (n=11).  The least common 
types of documents submitted were letters from tobacco control interest groups to the 
committees (n=3), and questions prepared by the tobacco control interest groups directed at the 
industry (n=1). 
The presentations and submissions in the sample were made by eight tobacco control 
interest groups.  The interest groups engaged in health advocacy were categorized as Tobacco 
Control Specific Organization (organizations that’s main objective is tobacco control, for 
 9 
example the Non-Smokers’ Rights Association), Health Advocacy Group (organizations that 
have a broad  mandate of improving health or are disease-specific, for example, the Canadian 
Cancer Society), or Professional Organization (organizations that represent the interests of a 
specific profession, for example, the Canadian Medical Association and the Canadian 
Association of Fire Chiefs).  The Non-Smokers’ Rights Association (NSRA) made the most 
submissions (n=14, Table 3) however, thirteen of these were made to the same committee 
regarding the same bill (C-71).  The organization that made the largest total number of 
presentations and submissions to committees regarding different bills was the Canadian Cancer 
Society (CCS) (n=4 submissions regarding different bills, n=4 presentations).   
Groups have an opportunity to express support or opposition for the bill in both their 
submissions and their presentations.  Professional Groups rarely expressed their view on the 
legislation.  The only example in the sample was the Canadian Association of Fire Chiefs who 
opposed Bill 260, An Act to amend the Hazardous Products Act (fire-safe cigarettes), because 
they favoured measures being taken by Health Canada.  Most Health Advocacy Groups did not 
express support or opposition for the bills either, but CCS did in three-quarters of submissions 
and presentations in the study.  The Tobacco Control Specific Organizations explicitly expressed 
support or opposition more frequently (n=13) than the other two categories (combined, n=7).  
They were also more likely to express this support during a presentation than in a submission.   
The report written by the Standing Senate Committee on Social Affairs, Science and 
Technology on Bill S-13, An Act to incorporate and to establish an industry levy to provide for 
the Canadian Tobacco Industry Community Responsibility Foundation, mentions that it was 
supported by over one hundred groups and organizations across Canada.  The tobacco control 
interest groups identified in the report included the Canadian Cancer Society, the Canadian 
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Medical Association, and the Heart and Stroke Association.  The only tobacco control interest 
group found in this study to support Bill S-13 was the Quebec Coalition for Tobacco Control, 
suggesting that organizations may state their support in other ways that were not examined in 
this study, for example conversations (in person or on the telephone), through the media, or press 
releases which were outside of the purview of this study. 
Did the tobacco control interest groups present scientific evidence to support tobacco 
control?  There is evidence that scientific evidence was part of the process.  This includes 
providing journal articles to the committee (n= 11) and citing journal articles in briefs (n= 12 of 
12).  These articles include both systematic reviews and epidemiological studies.  This is 
important because there is strong available evidence in favour of tobacco control and this 
analysis demonstrates that science was introduced to the policy making process. 
Did the tobacco control interest groups offer credible witnesses to present at meetings?  
The organizations did not provide scientists or medical experts as witnesses; instead the 
presenters were always a spokesperson from the tobacco control interest groups.  This might be 
seen as a deficit in the tobacco control interest groups’ overall tobacco prevention strategy.  This 
is an underutilized method of influencing policymakers; both Bero et al.14 stressed the 
importance of providing scientists as witnesses.  This is important because policy-makers rate 
witnesses provided by tobacco control interest groups as more credible than the lawyers and 
scientists provided by the tobacco industry as witnesses.9  Did the tobacco control interest groups 
present content themes that were consistent with the theme of the bill under consideration?  
Despite not explicitly supporting the legislation in the submissions and presentations, tobacco 
control interest groups were generally on topic with the bill.  The most common themes tobacco 
control interest groups mentioned were tobacco advertising, promotion and sponsorship (n=42, 
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combined presentations and submissions), and youth smoking (n=37, combined presentations 
and submissions).  This is not surprising, since two bills were regarding tobacco advertising, 
promotion and sponsorship (C-71 and C-42), and three bills were regarding youth smoking (C-
71, S-15, and S-20).  In submissions and presentations regarding C-71 and C-42, 81% mentioned 
the theme of tobacco advertising, promotion and sponsorship, while 86% of the submissions and 
presentations regarding C-71, S-15, and S-20 mentioned the theme of youth smoking.  All of the 
submissions and presentations regarding C-260 mentioned the theme of hazardous products.  
Other commonly mentioned themes include education (n=23, combined presentations and 
submissions), health effect of smoking (n=22, combined presentations and submissions), and tax 
(n=22, combined presentations and submissions).  Themes that were not commonly mentioned 
include personal rights (n=2, combined presentations and submissions), environmental damage 
(n=5, combined presentations and submissions), and farming/trade (n=5, combined presentations 
and submissions). 
Limitations 
This study did not examine if submissions or presentations were more effective in 
influencing policymakers; future research is needed to link the process to outcomes.  As well, 
this study employed a content analysis of presented material – an analysis of discursive devices 
or other subtle ways to influence decision-making might reveal further insights about the policy 
process.  
Examining one aspect of the legislative process (i.e., Parliamentary Committee meetings) 
excludes issues and topics that are dismissed at earlier stages and actors who participate in other 
stages.  The two committees that did not provide the requested documents were the House of 
Commons Standing Committee on Finance and the Senate Standing Committee on Banking, 
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Trade and Commerce, which both reviewed finance bills, including bill involving tobacco taxes.  
Thus, the exclusion of these submissions limits the scope of topics and the range of actors 
examined in this paper.  This study provides a description of the themes presented by Tobacco 
Control Interest Groups and not an evaluation of the submissions or issues presented.  As well, 
this study did not evaluate the scientific evidence provided by the Tobacco Control Interest 
Groups to determine if it was the best available evidence or properly interpreted.  This study was 
unable to examine the third part of Monini and Bero’s framework1, that is, the need to 
understand factors, outside of science, that affect policy-making.  Due to limited resources, the 
authors did not have the ability to review French language submissions; however this did not 
exclude traditionally French language groups (for example, Info-Tabac and Coalition québécoise 
pour le contrôle du tabac) because many of the submissions were translated into English and the 
transcripts of the committee meetings are provided in both official languages. 
The strength of this study is that it is the first to examine the content and organizational 
affiliation of parliamentary committee submissions related to federal tobacco control bills.  The 
hope is that this analysis will stimulate further work in this important policy area. 
Conclusion 
 Using presentations and submissions to parliamentary committees, the influence of 
tobacco control interest groups were analyzed using a qualitative content analysis and the 
framework set out by Montini and Bero’s.1  Tobacco Control Interest Groups employed some of 
the strategies suggested by Montini and Bero’s1 in their attempt to influence parliament 
committees through submissions and presentations.  They did provide scientific evidence in both 
the form of submitted articles and referencing articles in submitted documents and presentations.  
There was also some evidence that they understand other factors (outside of science) that 
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influence policy-making; however this needs further investigation.  An area where tobacco 
control interest groups can improve is in providing credible witnesses, for example, scientists 
and medical experts, in addition to employees of the organization.  Incorporating Montini and 
Bero’s1 recommendations into lobbying efforts may increase success in influencing committees 
not only for tobacco control interest groups but also for other public health advocates working in 
similar areas.
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Table 1: Bills examined 
Bill 
Number 
Bill Title Parliament, Session 
(Start/End Dates) 
Committees 
C-71 An Act to regulate the 
manufacture, sale, labeling and 
promotion of tobacco products, 
to make consequential 
amendments to another Act 
and to repeal certain Acts 
35th Parl, 2nd Sess 
(February 27, 1996 – 
April 27, 1997) 
Senate Committee – 
Legal & Constitutional 
Affairs 
S-5 An Act to restrict the 
manufacture, sale, importation 
and labeling of tobacco 
products 
35th Parl, 2nd Sess 
(February 27, 1996–
April 27, 1997) 
Senate Committee – 
Social Affairs, Science & 
Technology 
C-42 An Act to amend the Tobacco 
Act 
36th Parl, 1st Sess 
(September 22, 1997–
September 18, 1998) 
Senate Committee – 
Legal & Constitutional 
Affairs 
S-13 An Act to incorporate and to 
establish an industry levy to 
provide for the Canadian 
Tobacco Industry Community 
Responsibility Foundation 
36th Parl, 1st Sess 
(September 22, 1997–
September 18, 1999) 
Senate Committee – 
Social Affairs, Science & 
Technology 
S-20 An Act to enable and assist the 
Canadian tobacco industry in 
36th Parl, 2nd Sess 
(October 12, 1999–
Senate Committee- 
Energy, the Environment 
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attaining its objective of 
preventing the use of tobacco 
by young persons in Canada 
October 22, 2000) and Natural Resources 
S-15 An Act to enable and assist the 
Canadian tobacco industry in 
attaining its objective of 
preventing the use of tobacco 
by young persons in Canada 
37th Parl, 1st Sess 
(January 29, 2001–
September 16, 2002) 
Senate Committee- 
Energy, the Environment 
and Natural Resources 
C-260 An Act to amend the 
Hazardous Products Act (fire-
safe cigarettes) 
37th Parl, 2nd Sess 
(September 30, 2002–
November 12, 2003) 
House of Commons – 
Standing Committee on 
Health 
 
Table 2: Coding Instrument 
Items in Instrument Code Categories Operational 
Definitions 
Research Question 
Addressed 
Non-Smokers’ Rights 
Association 
Canadian Cancer 
Society 
Ontario Campaign for 
Action on Tobacco 
Info-Tabac 
Affiliation 
Physicians for a 
The affiliation listed 
in the committee 
meeting minutes or 
the organization that 
submitted documents 
to the committee 
Description of 
Participants 
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Smoke-Free Canada 
National Cancer 
Institute of Canada 
Coalition québécoise 
pour le contrôle du 
tabac 
 
Canadian Association 
of Fire Chiefs 
  
Brief A document 
providing background 
on the issue prepared 
by the organization 
Description of 
Participants 
Speaking notes for 
presentation 
Power point slides 
and speaking notes 
for presentations to 
the committee 
(corresponds a 
presentation in the 
committee meeting 
transcript) 
Type 
Letter Letters to the 
committee from the 
organization 
Description of 
Participants 
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Research/Article Copies of journal 
articles 
Description of 
Participants and 
Question 1: provide 
scientific evidence to 
support tobacco 
control 
Questions Lists of questions 
provided by an 
organization for the 
committee to ask 
other organizations 
(e.g., tobacco industry 
representatives) 
Transcript of 
Committee Meeting 
Transcripts of the 
committee meetings 
available on the 
committee website 
 
Newsletter/Memo A document provide 
to the committee from 
an organization that 
was originally 
produced as an 
memorandum or 
Description of 
Participants 
Description of 
Participants 
Description of 
Participants 
Description of 
Participants 
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organizational 
newsletter 
 
Other Items that did not fit 
into the above 
categories, e.g., other 
types of documents, 
art work, or 
advertisements 
 
House of Commons 
Standing Committee on 
Health 
House of Commons 
Standing Committee on 
Finance 
Senate Standing 
Committee on Social 
Affairs, Science and 
Technology 
Senate Standing 
Committee on Legal 
and Constitutional 
Affairs 
Which Committee 
Senate Standing 
To which committee 
was the information 
submitted/presented 
Description of 
Participants 
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Committee on Energy, 
the Environment and 
Natural Resources 
 
Senate Standing 
Committee on Banking, 
Trade and Commerce 
  
C-11 
C-71 
C-42 
C-26 
C-47 
C-260 
S-5 
S-8 
S-13 
S-20 
Which Bill 
S-15 
Which bill was the 
information 
submitted/presented 
in regard to 
Description of 
Participants 
Primary research 
conducted by the 
organization 
References 
Research from other 
Tobacco Control 
Interest Groups 
Description of the 
research cited by the 
organization in their 
submissions and 
presentations 
Question 1: provide 
scientific evidence to 
support tobacco 
control 
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Government 
Report/Publication 
Journal Article 
Monograph 
Tobacco Industry Paper 
 
Symposium/Conference 
Presentation 
  
Executive Director 
Director 
President 
Vice President 
Program Manage 
Senior Policy Analyst 
Legal Counsel 
Coordinator 
Health Consultant 
Physician/Doctor 
Title of Presenter 
Scientist/Researcher 
From the committee 
meeting minutes 
Question 2: Offer 
credible witnesses to 
present at meetings 
Health effects of 
smoking 
e.g., cancer, cardio-
vascular disease, lung 
disease 
Themes 
Second-hand smoke 
issues 
The harm of second-
hand smoke, and 
Question 3: what 
themes did they 
present in their 
presentations and 
submissions? 
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location – in public, 
inside/outside, in 
private. 
Tobacco consumption Rates and trends of 
tobacco consumption 
Tobacco advertising, 
promotion, sponsorship 
Limitations on 
tobacco advertising, 
promotion and 
sponsorship 
Economic issues Costs to society, 
government, 
individual 
Farming and trade Economic issues 
related to farming and 
trade, and 
compensation to 
tobacco farmers 
Product issue Design of tobacco 
products (e.g., vents) 
 
Addiction Information related to 
addictive properties 
of tobacco (e.g., 
nicotine) 
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Youth access issues Sales to youth, buying 
for youth, product 
targeted to youth (for 
example, smokeless 
tobacco products) 
Education, prevention 
& cessation 
programmes, services 
and campaigns 
Discussion of 
programmes or 
services available or 
proposed to educate 
the public about the 
harm of tobacco and 
cessation programs 
Environmental damage  e.g., fire, litter 
Tobacco industry References to the 
tobacco industry (e.g., 
past actions, reactions 
to bill) 
Denormalization Campaigns revealing 
the lies to and 
manipulation of the 
public by the tobacco 
industry 
 
Warning labels Warning labels on 
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cigarette packages, 
including the pictures 
and phrases 
Sales location Issues at the location 
of sale, where 
cigarettes are sold, 
advertising in stores. 
Tax Changes in taxation 
of tobacco, use of 
tobacco tax revenue 
Smuggling Smuggling from other 
jurisdictions 
Packaging Plain packaging 
Contraband Contraband products 
Labeling  Tobacco products 
labeled Light/Mild 
Other tobacco products Smokeless tobacco, 
chewing tobacco, 
flavoured tobacco 
 
Legislation/regulation Legislation/ 
Regulation in other 
jurisdiction and how 
it can be applied to 
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the situation 
Legal issues Potential legal issues 
that can be foreseen 
with the legislation or 
faced in other 
jursidications 
Hazardous products Classifying tobacco 
as a hazardous 
product 
First Nations issues Traditional uses of 
tobacco 
Personal right Right to smoke vs. 
right not to be 
exposed to second-
hand smoke 
 
Other Issues not mentioned 
above 
 
Yes 
No 
Support the Bill 
Yes, with amendments 
Stating support or 
opposition to the bill 
in the presentation or 
presentation 
 
Recommendations Addition Recommendation that 
an amendment be 
 
 27 
added to the bill 
Deletion Recommendation that 
a section be removed 
from the bill 
 
Table 3: Type of submission by tobacco interest group* 
 Brief Letter Article Questions Newsletter/ 
Memo 
Other Total 
Non-Smokers’ 
Rights Association 
2  6  3 3 
14 
Canadian Cancer 
Society 
3 1 1  1  
6 
Ontario Campaign 
for Action on 
Tobacco 
  1    
1 
Info-Tabac 1      1 
Physicians for a 
Smoke-Free 
Canada 
1 1 1  1 1 
5 
National Cancer 
Institute of Canada 
2     1 
3 
Coalition 
québécoise pour le 
3  2 1 1 1 
8 
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contrôle du tabac 
Canadian 
Association of Fire 
Chiefs 
 1     
1 
Total 12 3 11 1 6 6 39 
* Includes multiple submissions regarding the same bill 
